Cargando…
Anti-IL-17 Antibody Improves Hepatic Steatosis by Suppressing Interleukin-17-Related Fatty Acid Synthesis and Metabolism
To investigate the relationship between interleukin-17 and proteins involved in fatty acid metabolism with respect to alcoholic liver disease, male ICR mice were randomized into five groups: control, alcoholic liver disease (ALD) at 4 weeks, 8 weeks, and 12 weeks, and anti-IL-17 antibody treated ALD...
Autores principales: | Shi, Weidong, Zhu, Qiang, Gu, Jian, Liu, Xiaoshan, Lu, Ling, Qian, Xiaofeng, Shen, Jian, Zhang, Feng, Li, Guoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876773/ https://www.ncbi.nlm.nih.gov/pubmed/24396389 http://dx.doi.org/10.1155/2013/253046 |
Ejemplares similares
-
Antibodies attack IL-17
por: Maxmen, Amy
Publicado: (2010) -
Effects of interleukin 17A (IL-17A) neutralization on murine hepatitis virus (MHV-A59) infection
por: Aparicio, José L., et al.
Publicado: (2017) -
Interleukin-17 Contributes to the Pathogenesis of Autoimmune Hepatitis through Inducing Hepatic Interleukin-6 Expression
por: Zhao, Li, et al.
Publicado: (2011) -
Is Interleukin 17 (IL-17) Expression A Common Point in the Pathogenesis of Depression and Obesity?
por: Bliźniewska-Kowalska, Katarzyna, et al.
Publicado: (2020) -
Interleukin-17A (IL-17A): A silent amplifier of COVID-19
por: Maione, Francesco, et al.
Publicado: (2021)